NIDEK Microperimeter MP-3
Microperimeter
NIDEK Microperimeter MP-3 – advanced ophthalmic device for diagnosing and managing fixation disorders in both children and adults.
NIDEK Microperimeter MP-3
NIDEK
NIDEK Microperimeter MP-3 – a new-generation ophthalmic device combining visual field testing with high-resolution fundus imaging. Equipped with auto tracking and alignment, it delivers accurate and reliable results. It is especially valuable not only for adults but also for children with amblyopic deviations, enabling detection and management of central fixation disorders. The MP-3 also offers biofeedback training to support visual rehabilitation.
Detailed information
Structural and functional assessment with microperimetry and fundus imaging
Wide measurement range – The MP-3 provides visual field testing from 0 to 34 dB, enabling precise assessment even in normal eyes. A maximum stimulus luminance of 10,000 asb allows evaluation of low-sensitivity areas.
Fixation test and precise tracking system – Continuous eye tracking identifies the preferred retinal locus (PRL), evaluates fixation stability, and monitors improvements after treatment in patients with central field defects.
High-resolution fundus camera – The integrated 12-megapixel non-mydriatic fundus camera captures detailed retinal images without pupil dilation.
Visual rehabilitation – The biofeedback training mode helps low-vision patients relocate their preferred retinal locus to a trained retinal locus, improving fixation stability and reading speed.
Scotopic microperimetry (MP-3 type S) – Assesses rod function under low-light conditions, useful in age-related macular degeneration and certain types of retinitis pigmentosa, as well as in clinical trials.
Auto tracking and alignment – Improve measurement accuracy and ensure consistent follow-up exams.
Region-specific evaluation – Allows analysis of results in defined regions of interest for easier comparison with pathology images.
Follow-up testing and comparison – Enables repeated exams with identical parameters, supporting disease progression analysis and treatment outcome assessment.
